Adverse drug reaction

Ensuring patient safety is extremely important to Teva and we take the safety of all our products seriously.

Teva continuously monitors the safety of its products (both drugs and devices) by collecting information on adverse drug reactions. It is vital that the safety of all medicines is monitored throughout their marketed life - this is known as pharmacovigilance.

In the event that a product causes an adverse drug reaction, please let us know. The more we understand about the effects of our products, the more can be done to improve their safe use for the future.

 

We may contact you to find out more details about your report; however, we are unable to provide medical advice on your reactions.

 

If you are concerned about your reactions, or if they worsen, you should contact your healthcare professional.

 

If you would prefer, please inform about the adverse drug reaction using the contact details below:

 

 

Lithuania:
Address: UAB Sicor Biotech, Lvovo str. 25, Vilnius LT–09320, Lithuania
Phone: +370 5 2660203
E-mail: reaction@sicor.lt

You can also report side effects directly via the national reporting system:
By fax: +370-800 201 31
E-mail: NepageidaujamaR@vvkt.lt

Latvia:
Address: UAB Sicor Biotech Latvian Branch, 1 Zala Str., Riga, LV-1010
Phone: +371 67 323 666
E-mail: reaction@teva.lv

You can also report side effects directly via the national reporting system:
By phone: + 371 67078442
Fax: +371 67078428
Post: 15 Jersikas Str., Riga, LV-1003

Estonia:
Address: UAB Sicor Biotech Eesti filial, Hallivanamehe 4, Tallinn 11317, Estonia

Phone: +372 661 0801
E-mail: reaction@teva.ee
You can also report side effects directly via the national reporting system www.ravimiamet.ee


 

The information you provide will be recorded by Teva as part of its pharmacovigilance obligations. This information may be shared with other Teva entities and national and European authorities to be evaluated and collated with other adverse events recorded about that product or active ingredient. Further information can be found in a more detailed notice here. If you are not the subject of the report, whilst you do not need to obtain the patient’s consent to submit their information, you should direct the patient to this notice.